These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 32032255)
1. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CAN CATEGORIZE DIFFERENT SUBGROUPS OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Arrigo A; Romano F; Aragona E; Di Nunzio C; Battista M; Bandello F; Battaglia Parodi M Retina; 2020 Dec; 40(12):2263-2269. PubMed ID: 32032255 [TBL] [Abstract][Full Text] [Related]
2. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration. Lee JY; Chung H; Kim HC Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799 [TBL] [Abstract][Full Text] [Related]
3. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies. Steinle NC; Du W; Gibson A; Saroj N Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314 [TBL] [Abstract][Full Text] [Related]
4. Advanced Optical Coherence Tomography Angiography Analysis of Age-related Macular Degeneration Complicated by Onset of Unilateral Choroidal Neovascularization. Arrigo A; Aragona E; Capone L; Pierro L; Romano F; Bandello F; Parodi MB Am J Ophthalmol; 2018 Nov; 195():233-242. PubMed ID: 30098346 [TBL] [Abstract][Full Text] [Related]
5. OCT-Angiography for monitoring and managing neovascular age-related macular degeneration. Malamos P; Tsolkas G; Kanakis M; Mylonas G; Karatzenis D; Oikonomopoulos N; Lakoumentas J; Georgalas I Curr Eye Res; 2017 Dec; 42(12):1689-1697. PubMed ID: 28937833 [TBL] [Abstract][Full Text] [Related]
6. Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration. Nicholson BP; Nigam D; Toy B; Stetson PF; Agrón E; Jacobs-El N; Cunningham D; Cukras C; Wong W; Wiley H; Chew E; Ferris F; Meyerle CB Retina; 2015 Jan; 35(1):58-68. PubMed ID: 25077529 [TBL] [Abstract][Full Text] [Related]
7. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Lee H; Ji B; Chung H; Kim HC Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214 [TBL] [Abstract][Full Text] [Related]
8. Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial. Abdelfattah NS; Hariri AH; Al-Sheikh M; Pitetta S; Ebraheem A; Wykoff CC; Sadda SR; Am J Ophthalmol; 2018 Aug; 192():84-90. PubMed ID: 29763612 [TBL] [Abstract][Full Text] [Related]
9. CHOROIDAL IMAGING BIOMARKERS TO PREDICT HIGHLY RESPONSIVE AND RESISTANT CASES TREATED WITH STANDARDIZED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR REGIMEN IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Jhingan M; Cavichini M; Amador M; Dans K; Bartsch DU; Cheng L; Chhablani J; Freeman WR Retina; 2021 Oct; 41(10):2115-2121. PubMed ID: 34543243 [TBL] [Abstract][Full Text] [Related]
10. Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection. Lee JE; Kim HW; Lee SJ; Lee JE Retina; 2015 May; 35(5):999-1006. PubMed ID: 25590857 [TBL] [Abstract][Full Text] [Related]
11. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study. Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561 [TBL] [Abstract][Full Text] [Related]
13. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome. Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838 [TBL] [Abstract][Full Text] [Related]
14. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ; Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095 [TBL] [Abstract][Full Text] [Related]
15. 10-YEAR FOLLOW-UP OF A SUBCLINICAL CHOROIDAL NEOVASCULAR MEMBRANE IN A PATIENT WITH AGE-RELATED MACULAR DEGENERATION. Chen KG; Christakis PG; Chew EY Retin Cases Brief Rep; 2021 May; 15(3):207-210. PubMed ID: 30325876 [TBL] [Abstract][Full Text] [Related]
16. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN A CASE OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO TRAUMATIC CHOROIDAL RUPTURE. Preziosa C; Corvi F; Pellegrini M; Bochicchio S; Rosar AP; Staurenghi G Retin Cases Brief Rep; 2020; 14(4):339-342. PubMed ID: 29553995 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration. Iacono P; Parodi MB; Introini U; La Spina C; Varano M; Bandello F Retina; 2014 Feb; 34(2):281-7. PubMed ID: 23851632 [TBL] [Abstract][Full Text] [Related]
18. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692 [TBL] [Abstract][Full Text] [Related]
19. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400 [TBL] [Abstract][Full Text] [Related]
20. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY. Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]